Corona Remedies IPO Day 3: Huge 69.44x Subscription Sparks Buzz; GMP Strengthens — Should Investors Apply?
December 10, 2025 (Navroze Bureau) ; The Corona Remedies IPO has emerged as one of the most talked-about public issues of the month, registering exceptionally strong investor response as it entered Day 3 […]

